Revolutionising cardiovascular diagnosis

We are building world-class diagnostic aids to help cardiologists — powered by artificial intelligence.

To date, we have developed the world’s most accurate echocardiography software to improve the diagnosis of coronary heart disease by more than 90%.

How it Works

Watch our short explainer video to learn what problem we’re solving for clinicians and how our technology works.

Building on the Power of

Echocardiography

Echocardiography uses sound waves to image the heart. Because of its unparalleled safety profile, low cost and ease of deployment echo is the most widely used cardiac imaging test. Heart disease affects almost 50% of people over the age of 40 — making it the biggest killer globally. However, making a diagnosis from echo relies on experienced clinicians having to make qualitative judgements based on only a fraction of the data that is potentially available to them from a typical scan.

>90%

Increasing Accuracy with

Artificial Intelligence

Our technology extracts more than 80,000 data points from a single echocardiogram image to overcome subjectivity and increase diagnostic accuracy of coronary heart disease from 80% to >90%.

Our applications analyse all these data points using machine-learning techniques and have the potential to yield new, objective and highly diagnostic metrics about cardiac function and disease.

Our Path Forward

Anticipating the launch of our first stand-alone stress echocardiography product for cardiologists in 2019, underpinned by clinically-validated and exclusively-licensed intellectual property, we also have a future product pipeline growing out of one of the world’s largest research databases of echo images.

Building on the foundation of almost a decade of imaging research by the team at Oxford University, we are excited to bring a new approach and standard to the world of cardiovascular diagnostics.

Interested in our product launch?

Stay updated with our product launch newsletter

By submitting your information you are consenting to receiving news and updates from Ultromics. Please see our privacy policy here for more information about how we use your information.